Report cover image

Global Conjunctivitis Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 180 Pages
SKU # APRC20278680

Description

Summary

According to APO Research, The global Conjunctivitis market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Conjunctivitis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Conjunctivitis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Conjunctivitis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Conjunctivitis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Conjunctivitis include Akorn (US), Allergan (US), Bausch & Lomb (US), Freda (CN), Sinqi (CN), Sun Pharmaceutical (ID), Univision (CN), Santen Pharmaceutical (JP) and Novartis (CH), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Conjunctivitis, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Conjunctivitis, also provides the sales of main regions and countries. Of the upcoming market potential for Conjunctivitis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Conjunctivitis sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Conjunctivitis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Conjunctivitis sales, projected growth trends, production technology, application and end-user industry.

Conjunctivitis Segment by Company

Akorn (US)
Allergan (US)
Bausch & Lomb (US)
Freda (CN)
Sinqi (CN)
Sun Pharmaceutical (ID)
Univision (CN)
Santen Pharmaceutical (JP)
Novartis (CH)
Conjunctivitis Segment by Type

Antibiotic
Ointment
Pills
Conjunctivitis Segment by Application

Adults
Children
Newborns
Conjunctivitis Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Conjunctivitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Conjunctivitis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Conjunctivitis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Conjunctivitis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Conjunctivitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Conjunctivitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

180 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Conjunctivitis Market Size, 2020 VS 2024 VS 2031
1.3 Global Conjunctivitis Market Size Estimates and Forecasts (2020-2031)
1.4 Global Conjunctivitis Sales Estimates and Forecasts (2020-2031)
1.5 Global Conjunctivitis Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Conjunctivitis Market Dynamics
2.1 Conjunctivitis Industry Trends
2.2 Conjunctivitis Industry Drivers
2.3 Conjunctivitis Industry Opportunities and Challenges
2.4 Conjunctivitis Industry Restraints
3 Conjunctivitis Market by Manufacturers
3.1 Global Conjunctivitis Revenue by Manufacturers (2020-2025)
3.2 Global Conjunctivitis Sales by Manufacturers (2020-2025)
3.3 Global Conjunctivitis Average Sales Price by Manufacturers (2020-2025)
3.4 Global Conjunctivitis Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Conjunctivitis Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Conjunctivitis Manufacturers, Product Type & Application
3.7 Global Conjunctivitis Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Conjunctivitis Market CR5 and HHI
3.8.2 Global Top 5 and 10 Conjunctivitis Players Market Share by Revenue in 2024
3.8.3 2024 Conjunctivitis Tier 1, Tier 2, and Tier 3
4 Conjunctivitis Market by Type
4.1 Conjunctivitis Type Introduction
4.1.1 Antibiotic
4.1.2 Ointment
4.1.3 Pills
4.2 Global Conjunctivitis Sales by Type
4.2.1 Global Conjunctivitis Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Conjunctivitis Sales by Type (2020-2031)
4.2.3 Global Conjunctivitis Sales Market Share by Type (2020-2031)
4.3 Global Conjunctivitis Revenue by Type
4.3.1 Global Conjunctivitis Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Conjunctivitis Revenue by Type (2020-2031)
4.3.3 Global Conjunctivitis Revenue Market Share by Type (2020-2031)
5 Conjunctivitis Market by Application
5.1 Conjunctivitis Application Introduction
5.1.1 Adults
5.1.2 Children
5.1.3 Newborns
5.2 Global Conjunctivitis Sales by Application
5.2.1 Global Conjunctivitis Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Conjunctivitis Sales by Application (2020-2031)
5.2.3 Global Conjunctivitis Sales Market Share by Application (2020-2031)
5.3 Global Conjunctivitis Revenue by Application
5.3.1 Global Conjunctivitis Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Conjunctivitis Revenue by Application (2020-2031)
5.3.3 Global Conjunctivitis Revenue Market Share by Application (2020-2031)
6 Global Conjunctivitis Sales by Region
6.1 Global Conjunctivitis Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Conjunctivitis Sales by Region (2020-2031)
6.2.1 Global Conjunctivitis Sales by Region (2020-2025)
6.2.2 Global Conjunctivitis Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Conjunctivitis Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Conjunctivitis Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Conjunctivitis Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Conjunctivitis Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Conjunctivitis Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Conjunctivitis Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Conjunctivitis Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Conjunctivitis Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Conjunctivitis Revenue by Region
7.1 Global Conjunctivitis Revenue by Region
7.1.1 Global Conjunctivitis Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Conjunctivitis Revenue by Region (2020-2025)
7.1.3 Global Conjunctivitis Revenue by Region (2026-2031)
7.1.4 Global Conjunctivitis Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Conjunctivitis Revenue (2020-2031)
7.2.2 North America Conjunctivitis Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Conjunctivitis Revenue (2020-2031)
7.3.2 Europe Conjunctivitis Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Conjunctivitis Revenue (2020-2031)
7.4.2 Asia-Pacific Conjunctivitis Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Conjunctivitis Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Conjunctivitis Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Akorn (US)
8.1.1 Akorn (US) Comapny Information
8.1.2 Akorn (US) Business Overview
8.1.3 Akorn (US) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Akorn (US) Conjunctivitis Product Portfolio
8.1.5 Akorn (US) Recent Developments
8.2 Allergan (US)
8.2.1 Allergan (US) Comapny Information
8.2.2 Allergan (US) Business Overview
8.2.3 Allergan (US) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Allergan (US) Conjunctivitis Product Portfolio
8.2.5 Allergan (US) Recent Developments
8.3 Bausch & Lomb (US)
8.3.1 Bausch & Lomb (US) Comapny Information
8.3.2 Bausch & Lomb (US) Business Overview
8.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Bausch & Lomb (US) Conjunctivitis Product Portfolio
8.3.5 Bausch & Lomb (US) Recent Developments
8.4 Freda (CN)
8.4.1 Freda (CN) Comapny Information
8.4.2 Freda (CN) Business Overview
8.4.3 Freda (CN) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Freda (CN) Conjunctivitis Product Portfolio
8.4.5 Freda (CN) Recent Developments
8.5 Sinqi (CN)
8.5.1 Sinqi (CN) Comapny Information
8.5.2 Sinqi (CN) Business Overview
8.5.3 Sinqi (CN) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sinqi (CN) Conjunctivitis Product Portfolio
8.5.5 Sinqi (CN) Recent Developments
8.6 Sun Pharmaceutical (ID)
8.6.1 Sun Pharmaceutical (ID) Comapny Information
8.6.2 Sun Pharmaceutical (ID) Business Overview
8.6.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sun Pharmaceutical (ID) Conjunctivitis Product Portfolio
8.6.5 Sun Pharmaceutical (ID) Recent Developments
8.7 Univision (CN)
8.7.1 Univision (CN) Comapny Information
8.7.2 Univision (CN) Business Overview
8.7.3 Univision (CN) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Univision (CN) Conjunctivitis Product Portfolio
8.7.5 Univision (CN) Recent Developments
8.8 Santen Pharmaceutical (JP)
8.8.1 Santen Pharmaceutical (JP) Comapny Information
8.8.2 Santen Pharmaceutical (JP) Business Overview
8.8.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Santen Pharmaceutical (JP) Conjunctivitis Product Portfolio
8.8.5 Santen Pharmaceutical (JP) Recent Developments
8.9 Novartis (CH)
8.9.1 Novartis (CH) Comapny Information
8.9.2 Novartis (CH) Business Overview
8.9.3 Novartis (CH) Conjunctivitis Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Novartis (CH) Conjunctivitis Product Portfolio
8.9.5 Novartis (CH) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Conjunctivitis Value Chain Analysis
9.1.1 Conjunctivitis Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Conjunctivitis Production Mode & Process
9.2 Conjunctivitis Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Conjunctivitis Distributors
9.2.3 Conjunctivitis Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.